Aristeia Capital’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Aristeia Capital’s Portfolio HAIAW Stock Details HAIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-250,000	Closed	-$6.86K	–	471
2024 Q3	$6.86K	Hold	250,000	–	–	﹤0.01%	342
2024 Q2	$13.1K	Hold	250,000	–	–	﹤0.01%	299
2024 Q1	$9.32K	Hold	250,000	–	–	﹤0.01%	269
2023 Q4	$9.7K	Hold	250,000	–	–	﹤0.01%	177
2023 Q3	$14.4K	Hold	250,000	–	–	﹤0.01%	190
2023 Q2	$17.7K	Hold	250,000	–	–	﹤0.01%	209
2023 Q1	$33.8K	Hold	250,000	–	–	﹤0.01%	280
2022 Q4	$14.4K	Hold	250,000	–	–	﹤0.01%	429
2022 Q3	$36K	Hold	250,000	–	–	﹤0.01%	495
2022 Q2	$45K	Hold	250,000	–	–	﹤0.01%	529
2022 Q1	$47K	Buy	+250,000	New	+$75.4K	﹤0.01%	652

Other funds holding HAIAW

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Aristeia Capital's HAIAW Position: Q4 2024 in Review

Aristeia Capital sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2024, closing a stake of 250,000 shares — an estimated $6.86K sold.

Aristeia Capital first reported a position in HAIAW in Q1 2022 and held it in 11 quarters. The position peaked at $47K in Q1 2022. 3 funds tracked by Wall St. Rank hold HAIAW as of Q4 2024.

Aristeia Capital reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2024 after selling out during the quarter.
Aristeia Capital sold 250,000 Healthcare AI Acquisition Corp. Warrants shares in Q4 2024, an estimated $6.86K.
Aristeia Capital first reported a position in Healthcare AI Acquisition Corp. Warrants in Q1 2022 and held it in 11 quarters.
Aristeia Capital's Healthcare AI Acquisition Corp. Warrants position peaked at $47K in Q1 2022.
3 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2024.

Based on Aristeia Capital's 13F filing for Q4 2024, filed 14 Feb 2025.